id,source,text,arguments
0,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that can result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
1,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
2,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has the ability to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
3,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that is able to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
4,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that may have resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
5,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
6,EGRAM,A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that results in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.,"{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
7,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, can result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
8,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has resulted in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
9,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
10,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is able to result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
11,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is observed to result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
12,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may have resulted in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
13,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
14,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, resulted in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
15,EGRAM,"A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, will result in a Clr phenotype.","{'0': 'A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling', '1': 'a Clr phenotype'}"
16,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to result in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
17,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are observed to result in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
18,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can result in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
19,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation could have resulted in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
20,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have resulted in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
21,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have the ability to result in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
22,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
23,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation resulted in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
24,EGRAM,Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will result in mRNA species with distinct 5UTRs.,"{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation', '1': 'mRNA species with distinct 5UTRs'}"
25,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are able to result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
26,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are observed to result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
27,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, can result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
28,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, could have resulted in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
29,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have resulted in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
30,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have the ability to result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
31,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, may have resulted in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
32,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
33,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, resulted in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
34,EGRAM,"Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, will result in mRNA species with distinct 5UTRs.","{'0': 'Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,', '1': 'mRNA species with distinct 5UTRs'}"
35,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
36,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
37,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
38,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
39,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
40,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
41,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
42,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively) will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
43,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
44,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
45,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
46,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
47,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
48,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
49,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
50,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
51,EGRAM,"Both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a, respectively), in contrast, will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.","{'0': 'Both the 5 and 3 splice site mutations', '1': 'high proportions of mature mRNAs containing introns'}"
52,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being able to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
53,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being observed to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
54,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having resulted in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
55,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having the ability to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
56,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that has the ability to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
57,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is able to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
58,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is observed to result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
59,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that may have resulted in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
60,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that resulted in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
61,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which can result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
62,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which has resulted in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
63,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which results in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
64,EGRAM,Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which will result in the substitution of isoleucine for valine.,"{'0': 'a new mutation at codon 210', '1': 'the substitution of isoleucine for valine'}"
65,EGRAM,"Decreased EGL-15 signaling that can result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
66,EGRAM,"Decreased EGL-15 signaling that has resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
67,EGRAM,"Decreased EGL-15 signaling that has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
68,EGRAM,"Decreased EGL-15 signaling that is able to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
69,EGRAM,"Decreased EGL-15 signaling that is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
70,EGRAM,"Decreased EGL-15 signaling that may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
71,EGRAM,"Decreased EGL-15 signaling that may result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
72,EGRAM,"Decreased EGL-15 signaling that resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
73,EGRAM,"Decreased EGL-15 signaling that results in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
74,EGRAM,"Decreased EGL-15 signaling that will result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
75,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, can result in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
76,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has resulted in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
77,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
78,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is able to result in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
79,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
80,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
81,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may result in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
82,EGRAM,"Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, resulted in a scrawny body morphology phenotype(Kokel et al., 1998).","{'0': 'Decreased EGL-15 signaling', '1': 'a scrawny body morphology phenotype'}"
83,EGRAM,Exon 13 skipping in s1031 animals can finally result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
84,EGRAM,Exon 13 skipping in s1031 animals can result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
85,EGRAM,Exon 13 skipping in s1031 animals finally resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
86,EGRAM,Exon 13 skipping in s1031 animals has finally resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
87,EGRAM,Exon 13 skipping in s1031 animals has resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
88,EGRAM,Exon 13 skipping in s1031 animals has the ability to finally result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
89,EGRAM,Exon 13 skipping in s1031 animals has the ability to result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
90,EGRAM,Exon 13 skipping in s1031 animals has the probability of resulting in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
91,EGRAM,Exon 13 skipping in s1031 animals is able to finally result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
92,EGRAM,Exon 13 skipping in s1031 animals is able to result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
93,EGRAM,Exon 13 skipping in s1031 animals is shown to finally result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
94,EGRAM,Exon 13 skipping in s1031 animals is shown to result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
95,EGRAM,Exon 13 skipping in s1031 animals may have finally resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
96,EGRAM,Exon 13 skipping in s1031 animals may have resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
97,EGRAM,Exon 13 skipping in s1031 animals resulted in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
98,EGRAM,Exon 13 skipping in s1031 animals will finally result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
99,EGRAM,Exon 13 skipping in s1031 animals will result in a 543 bp product.,"{'0': 'Exon 13 skipping in s1031 animals', '1': 'a 543 bp product'}"
100,EGRAM,Expression of isoform II cDNA in COS7 cells are able to finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
101,EGRAM,Expression of isoform II cDNA in COS7 cells are able to result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
102,EGRAM,Expression of isoform II cDNA in COS7 cells are observed to finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
103,EGRAM,Expression of isoform II cDNA in COS7 cells are observed to result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
104,EGRAM,Expression of isoform II cDNA in COS7 cells can finally result in a marked increase in PAF acetylhydrolase activity,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
105,EGRAM,Expression of isoform II cDNA in COS7 cells can result in a marked increase in PAF acetylhydrolase activity,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
106,EGRAM,Expression of isoform II cDNA in COS7 cells finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
107,EGRAM,Expression of isoform II cDNA in COS7 cells has finally resulted in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
108,EGRAM,Expression of isoform II cDNA in COS7 cells has resulted in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
109,EGRAM,Expression of isoform II cDNA in COS7 cells have the ability to finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
110,EGRAM,Expression of isoform II cDNA in COS7 cells have the ability to result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
111,EGRAM,Expression of isoform II cDNA in COS7 cells may finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
112,EGRAM,Expression of isoform II cDNA in COS7 cells may have finally resulted in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
113,EGRAM,Expression of isoform II cDNA in COS7 cells may have resulted in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
114,EGRAM,Expression of isoform II cDNA in COS7 cells may result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
115,EGRAM,Expression of isoform II cDNA in COS7 cells result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
116,EGRAM,Expression of isoform II cDNA in COS7 cells will finally result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
117,EGRAM,Expression of isoform II cDNA in COS7 cells will result in a marked increase in PAF acetylhydrolase activity.,"{'0': 'Expression of isoform II cDNA in COS7 cells', '1': 'a marked increase in PAF acetylhydrolase activity'}"
118,EGRAM,Fluctuation in the ras-dependent signaling can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
119,EGRAM,Fluctuation in the ras-dependent signaling has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
120,EGRAM,Fluctuation in the ras-dependent signaling has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
121,EGRAM,Fluctuation in the ras-dependent signaling has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
122,EGRAM,Fluctuation in the ras-dependent signaling is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
123,EGRAM,Fluctuation in the ras-dependent signaling is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
124,EGRAM,Fluctuation in the ras-dependent signaling may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
125,EGRAM,Fluctuation in the ras-dependent signaling may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
126,EGRAM,Fluctuation in the ras-dependent signaling resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
127,EGRAM,Fluctuation in the ras-dependent signaling results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
128,EGRAM,Fluctuation in the ras-dependent signaling will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.,"{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
129,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
130,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
131,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
132,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
133,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
134,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
135,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
136,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
137,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
138,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
139,EGRAM,"Fluctuation in the ras-dependent signaling, as we predicted, will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.","{'0': 'fluctuation in the ras-dependent signaling', '1': 'a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present'}"
140,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
141,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
142,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
143,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
144,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having completely resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
145,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
146,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
147,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
148,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
149,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
150,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
151,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
152,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
153,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
154,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
155,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
156,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have completely resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
157,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
158,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
159,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
160,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have completely resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
161,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
162,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
163,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which resulted in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
164,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will completely result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
165,EGRAM,"Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will result in a super-repeat.","{'0': 'various alternate subdomains', '1': 'a super-repeat'}"
166,EGRAM,Induction of a mutation in the lacI gene can result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
167,EGRAM,Induction of a mutation in the lacI gene could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
168,EGRAM,Induction of a mutation in the lacI gene has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
169,EGRAM,Induction of a mutation in the lacI gene has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
170,EGRAM,Induction of a mutation in the lacI gene is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
171,EGRAM,Induction of a mutation in the lacI gene is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
172,EGRAM,Induction of a mutation in the lacI gene may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
173,EGRAM,Induction of a mutation in the lacI gene may result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
174,EGRAM,Induction of a mutation in the lacI gene resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
175,EGRAM,Induction of a mutation in the lacI gene results in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
176,EGRAM,Induction of a mutation in the lacI gene will result in the loss of transcriptional repression of the lacZ gene in mutated cells.,"{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
177,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, can result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
178,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
179,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
180,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
181,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
182,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
183,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
184,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, may result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
185,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
186,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, results in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
187,EGRAM,"Induction of a mutation in the lacI gene, as our study revealed, will result in the loss of transcriptional repression of the lacZ gene in mutated cells.","{'0': 'Induction of a mutation in the lacI gene', '1': 'the loss of transcriptional repression of the lacZ gene'}"
188,EGRAM,Mutations being able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
189,EGRAM,Mutations being observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
190,EGRAM,Mutations having resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
191,EGRAM,Mutations having the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
192,EGRAM,Mutations resulting in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
193,EGRAM,Mutations that are able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
194,EGRAM,Mutations that are observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
195,EGRAM,Mutations that can result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
196,EGRAM,Mutations that have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
197,EGRAM,Mutations that have the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
198,EGRAM,Mutations that may have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
199,EGRAM,Mutations that may result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
200,EGRAM,Mutations that result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
201,EGRAM,Mutations that resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
202,EGRAM,Mutations that will result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
203,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are able to result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
204,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are observed to result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
205,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites can result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
206,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have resulted in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
207,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have the ability to result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
208,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may have resulted in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
209,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
210,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
211,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites resulted in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
212,EGRAM,Mutations which prevent repressor binding to either site or alter the phasing of the binding sites will result in simultaneous derepression of both genes.,"{'0': 'Mutations', '1': 'simultaneous derepression of both genes'}"
213,EGRAM,One variant can probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
214,EGRAM,One variant can result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
215,EGRAM,One variant has been found to probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
216,EGRAM,One variant has been found to result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
217,EGRAM,One variant has probably resulted from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
218,EGRAM,One variant has resulted from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
219,EGRAM,One variant has shown to probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
220,EGRAM,One variant has shown to result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
221,EGRAM,One variant has the ability to probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
222,EGRAM,One variant has the ability to result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
223,EGRAM,One variant probably resulted from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
224,EGRAM,One variant resulted from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
225,EGRAM,One variant was able to probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
226,EGRAM,One variant was able to result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
227,EGRAM,One variant was observed to probably result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
228,EGRAM,One variant was observed to result from failure to use the normal splice donor site of intron 12.,"{'0': 'failure to use the normal splice donor site of intron 12', '1': 'One variant'}"
229,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins can resulted from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
230,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to result from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
231,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has resulted from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
232,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has the ability to result from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
233,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is able to result from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
234,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to result from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
235,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins may have resulted from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
236,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins resulted from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
237,EGRAM,Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins will result from alternative splicing of a single transcript.,"{'0': 'alternative splicing of a single transcript', '1': 'the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins'}"
238,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being able to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
239,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being able to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
240,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
241,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being observed to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
242,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
243,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit being shown to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
244,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit having finally resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
245,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit having resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
246,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit that has finally resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
247,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit that has resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
248,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit that will finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
249,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit that will result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
250,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which can finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
251,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which can result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
252,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which finally resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
253,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which finally results in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
254,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
255,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
256,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which is able to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
257,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which is able to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
258,EGRAM,The change may cause heat instability and affect the net charge of the variant subunit which is observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
259,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
260,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which may have finally resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
261,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which may have resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
262,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which resulted in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
263,EGRAM,The change may cause the heat instability and affect the net charge of the variant subunit which results in an electrophoretic LDH-B subunit variant of the fast type.,"{'0': 'the net charge of the variant subunit', '1': 'an electrophoretic LDH-B subunit variant of the fast type'}"
264,EGRAM,The research shows the existence of isoforms of NF-YA resulting from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
265,EGRAM,The research shows the existence of isoforms of NF-YA that results from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
266,EGRAM,The research shows the existence of isoforms of NF-YA which resulted from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
267,EGRAM,"These observations show that repression has been the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.","{'0': 'co-operative binding of the repressor to its two sites', '1': 'repression'}"
268,EGRAM,"These observations show that repression is believed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.","{'0': 'co-operative binding of the repressor to its two sites', '1': 'repression'}"
269,EGRAM,"These observations show that repression is observed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.","{'0': 'co-operative binding of the repressor to its two sites', '1': 'repression'}"
270,EGRAM,"These observations show that repression is the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.","{'0': 'co-operative binding of the repressor to its two sites', '1': 'repression'}"
271,EGRAM,"These observations show that repression may be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.","{'0': 'co-operative binding of the repressor to its two sites', '1': 'repression'}"
272,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are able to result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
273,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are observed to result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
274,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) can result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
275,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have been shown to result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
276,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have resulted in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
277,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the ability to result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
278,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the probability of resulting in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
279,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may have resulted in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
280,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
281,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
282,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) resulted in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
283,EGRAM,"Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) will result in truncated nonfunctional proteins.","{'0': 'the other three alterations', '1': 'truncated nonfunctional proteins'}"
284,EGRAM,We also report the existence of isoforms of NF-YA that will result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
285,EGRAM,We also reported the existence of isoforms of NF-YA being able to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
286,EGRAM,We also reported the existence of isoforms of NF-YA being shown to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
287,EGRAM,We also reported the existence of isoforms of NF-YA having resulted from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
288,EGRAM,We also reported the existence of isoforms of NF-YA having the ability to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
289,EGRAM,We also reported the existence of isoforms of NF-YA observed to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
290,EGRAM,We also reported the existence of isoforms of NF-YA that has been shown to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
291,EGRAM,We also reported the existence of isoforms of NF-YA that has resulted from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
292,EGRAM,We also reported the existence of isoforms of NF-YA that has the ability to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
293,EGRAM,We also reported the existence of isoforms of NF-YA that is able to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
294,EGRAM,We also reported the existence of isoforms of NF-YA that is observed to result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
295,EGRAM,We also reported the existence of isoforms of NF-YA that may have resulted from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
296,EGRAM,We also reported the existence of isoforms of NF-YA that may result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
297,EGRAM,We also reported the existence of isoforms of NF-YA which can result from differential splicing.,"{'0': 'differential splicing', '1': 'the existence of isoforms of NF-YA'}"
298,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation can result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
299,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation has been shown to result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
300,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation has resulted from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
301,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation has the ability to result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
302,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation is able to result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
303,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation is observed to result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
304,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation may have resulted from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
305,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation may result from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
306,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation resulted from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
307,EGRAM,We show that the negative effect of the cpxA mutation on biofilm formation results from a decreased transcription of the curlin encoding csgA gene.,"{'0': 'a decreased transcription of the curlin encoding csgA gene', '1': 'the negative effect of the cpxA mutation'}"
308,EGRAM,We speculated that this has been shown to be the result of the expression of isoforms of Nrf1 in mast cells.,"{'0': 'the expression of isoforms of Nrf1', '1': 'this'}"
309,EGRAM,We speculated that this is observed to be the result of the expression of isoforms of Nrf1 in mast cells.,"{'0': 'the expression of isoforms of Nrf1', '1': 'this'}"
310,EGRAM,We speculated that this is the result of the expression of isoforms of Nrf1 in mast cells.,"{'0': 'the expression of isoforms of Nrf1', '1': 'this'}"
311,EGRAM,We speculated that this may be the result of the expression of isoforms of Nrf1 in mast cells.,"{'0': 'the expression of isoforms of Nrf1', '1': 'this'}"
